Last $80.34 USD
Change Today +0.061 / 0.08%
Volume 792.4K
SYK On Other Exchanges
Symbol
Exchange
New York
Frankfurt
As of 2:04 PM 10/20/14 All times are local (Market data is delayed by at least 15 minutes).

stryker corp (SYK) Snapshot

Open
$79.82
Previous Close
$80.28
Day High
$80.55
Day Low
$79.63
52 Week High
06/20/14 - $86.93
52 Week Low
12/13/13 - $71.22
Market Cap
30.4B
Average Volume 10 Days
2.1M
EPS TTM
$4.29
Shares Outstanding
378.6M
EX-Date
09/26/14
P/E TM
18.7x
Dividend
$1.22
Dividend Yield
1.52%
Current Stock Chart for STRYKER CORP (SYK)

stryker corp (SYK) Details

Stryker Corporation, together with its subsidiaries, operates as a medical technology company. The company operates in three segments: Reconstructive, MedSurg, and Neurotechnology and Spine. The Reconstructive segment provides orthopaedic reconstructive implants used in hip and knee joint replacements; and trauma systems, as well as other related products. The MedSurg segment offers surgical equipment and surgical navigation systems, endoscopic and communications systems, patient handling and emergency medical equipment, and reprocessed and remanufactured medical devices, as well as other medical devices for use in various medical specialties. The Neurotechnology and Spine segment provides neurosurgical and neurovascular devices that include products for use in invasive endovascular techniques, products for traditional brain and open skull base surgical procedures, and orthobiologic and biosurgery products, as well as products for the treatment of acute ischemic and hemorrhagic stroke. This segment also develops, manufactures, and markets spinal implant products, including cervical, thoracolumbar, and interbody systems for use in spinal injury, deformity, and degenerative therapies. The company markets its products to doctors, hospitals, and other healthcare facilities in the United States, as well as sells its products through local dealers, direct sales, and third-party dealers and distributors in approximately 100 countries worldwide. Stryker Corporation was founded in 1941 and is headquartered in Kalamazoo, Michigan.

25,000 Employees
Last Reported Date: 02/13/14
Founded in 1941

stryker corp (SYK) Top Compensated Officers

Chairman and Chief Executive Officer
Total Annual Compensation: $1.0M
Chief Financial Officer and Vice President
Total Annual Compensation: $431.4K
Group President of Global Quality & Operation...
Total Annual Compensation: $407.4K
Group President of Medsurg & Neurotechnology
Total Annual Compensation: $553.3K
Group President of International
Total Annual Compensation: $512.5K
Compensation as of Fiscal Year 2013.

stryker corp (SYK) Key Developments

Stryker Corporation Reports Unaudited Consolidated Earnings Results for the Third Quarter and Nine Months Ended September 30, 2014; Provides Earnings Guidance for the Year 2014

Stryker Corporation reported unaudited consolidated earnings results for the third quarter and nine months ended September 30, 2014. For the quarter, the company's net sales were $2,389 million against $2,151 million a year ago. Operating income was $450 million against $150 million a year ago. Earnings before income taxes were $425 million against $137 million a year ago. Net earnings were $57 million against $103 million a year ago. Basic and diluted earnings per share were $0.16 against $0.27 a year ago. Net cash provided by operating activities was $535 million against $622 million a year ago. Purchases of property, plant and equipment was $48 million against $43 million a year ago. Adjusted operating income was $572 million against $525 million a year ago. Adjusted net earnings were $439 million or $1.15 diluted per share against $398 million or $1.04 diluted per share a year ago. For the nine months, the company's net sales were $7,057 million against $6,553 million a year ago. Operating income was $778 million against $826 million a year ago. Earnings before income taxes were $699 million against $781 million a year ago. Net earnings were $255 million against $620 million a year ago. Diluted earnings per share were $0.67 against $1.62 a year ago. Net cash provided by operating activities was $1,107 million against $1,214 million a year ago. Purchases of property, plant and equipment was $172 million against $139 million a year ago. Adjusted operating income was $1,693 million against $1,611 million a year ago. Adjusted earnings were $1,258 million or $3.29 diluted per share against $1,221 million or $3.20 diluted per share a year ago. Capital expenditures were $172 million compared to $139 million in the same period last year. Based on current foreign currency exchange rates, the company expects full year adjusted diluted net earnings per share to be at the low end of the previously disclosed range of $4.75 to $4.80. The company expects the full year rate will be approximately 22%, consistent with year-to-date adjusted effective tax rate.

WiLAN Subsidiary Enters License Agreement with Stryker Corporation

WiLAN announced that a wholly-owned subsidiary of the company has granted Stryker Corporation a license to certain patents related to medical stent technology. WiLAN secured the rights to license the patents through an agreement executed in June 2014. The consideration to be paid by Stryker to WiLAN and all other terms of the license agreement are confidential.

Stryker Corp. Seeking Acquisitions

Stryker Corporation (NYSE:SYK) emphasized they are still looking for acquisitions.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
SYK:US $80.34 USD +0.061

SYK Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Baxter International Inc $67.72 USD +0.4799
Becton Dickinson and Co $122.82 USD +1.09
Covidien PLC $83.87 USD +1.67
Ecolab Inc $109.31 USD +1.42
St Jude Medical Inc $58.52 USD +0.24
View Industry Companies
 

Industry Analysis

SYK

Industry Average

Valuation SYK Industry Range
Price/Earnings 47.9x
Price/Sales 3.2x
Price/Book 3.5x
Price/Cash Flow 37.1x
TEV/Sales 2.4x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact STRYKER CORP, please visit www.strykercorp.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.